Bactericidal potential of drugs targeting the mevalonate pathway

被引：0
|
作者：
Weber, L. [1 ]
Hagemann, A. [1 ]
Jebens, H. [1 ]
Besser, M. [2 ]
Schlobach, J. [2 ]
Rockenfeller, P. [3 ]
Ehrhardt, A. [4 ]
Stuermer, E. [2 ,5 ]
Bachmann, H. S. [1 ]
机构：
[1] Witten Herdecke Univ, Inst Pharmacol & Toxicol, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[2] Witten Herdecke Univ, Translat Wound Res, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[3] Witten Herdecke Univ, Inst Biochem & Mol Med, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[4] Witten Herdecke Univ, Inst Virol & Microbiol, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Vasc Med, Univ Heart Ctr, Translat Wound Res, Hamburg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2023年 / 396卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P007
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [31] Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages
    Munoz, Marcia A.
    Fletcher, Emma K.
    Skinner, Oliver P.
    Jurczyluk, Julie
    Kristianto, Esther
    Hodson, Mark P.
    Sun, Shuting
    Ebetino, Frank H.
    Croucher, David R.
    Hansbro, Philip M.
    Center, Jacqueline R.
    Rogers, Michael J.
    ELIFE, 2021, 10
  • [32] Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus, Wirginia
    Siemianowicz, Krzysztof
    Bienk, Konrad
    Pakula, Malgorzata
    Pathak, Himani
    Dutta, Chhanda
    Wang, Qiong
    Shojaei, Shahla
    Assaraf, Yehuda G.
    Ghavami, Saeid
    Cieslar-Pobuda, Artur
    Los, Marek J.
    DRUG RESISTANCE UPDATES, 2016, 25 : 13 - 25
  • [33] REGULATION OF THE MEVALONATE PATHWAY
    GOLDSTEIN, JL
    BROWN, MS
    NATURE, 1990, 343 (6257) : 425 - 430
  • [34] A mevalonate pathway–Hippo pathway connection
    Gemma K. Alderton
    Nature Reviews Cancer, 2014, 14 (5) : 298 - 298
  • [35] Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
    Zhou, Wei
    Liu, Heng
    Yuan, Zhe
    Zundell, Joseph
    Towers, Martina
    Lin, Jianhuang
    Lombardi, Simona
    Nie, Hao
    Murphy, Brennah
    Yang, Tyler
    Wang, Chen
    Liao, Liping
    Goldman, Aaron R.
    Kannan, Toshitha
    V. Kossenkov, Andrew
    Drapkin, Ronny
    Montaner, Luis J.
    Claiborne, Daniel T.
    Zhang, Nan
    Wu, Shuai
    Zhang, Rugang
    CANCER CELL, 2023, 41 (04) : 740 - +
  • [36] New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway
    van de Donk, NWCJ
    Bloem, AC
    van der Spek, E
    Lokhorst, HM
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 327 - 340
  • [37] Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance
    Hu, Huizhong
    Simon, Lukas M.
    Nardone, Agostina
    Shaw, Chad A.
    Chamness, Gary C.
    Heiser, Laura M.
    Wang, Nicholas
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2015, 75
  • [38] Biosynthesis of abscisic acid by the non-mevalonate pathway in plants, and by the mevalonate pathway in fungi
    Hirai, N
    Yoshida, R
    Todoroki, Y
    Ohigashi, H
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2000, 64 (07) : 1448 - 1458
  • [39] Therapeutic Potential of Targeting the Ghrelin Pathway
    Collden, Gustav
    Tschoep, Matthias H.
    Mueller, Timo D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
  • [40] Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway
    Mueller, Alison L.
    Freed, Darren H.
    CURRENT MOLECULAR PHARMACOLOGY, 2017, 10 (01) : 6 - 12
12345